- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Omnicell Inc (OMCL)
Omnicell Inc stock price live, this page displays NASDAQ OMCL stock exchange data. View the OMCL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Omnicell Inc real time stock price chart below.
What Is the Omnicell Inc Stock Price Today?
The Omnicell Inc stock price today is 42.94.
What Is the Stock Symbol for Omnicell Inc?
The stock ticker symbol for Omnicell Inc is OMCL.
Is OMCL the Same as $OMCL?
$OMCL is a common way to refer to the Omnicell Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Omnicell Inc Trade On?
Omnicell Inc is listed and trades on the NASDAQ stock exchange.
Is Omnicell Inc a Good Stock to Buy?
Determining whether Omnicell Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Omnicell Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OMCL quote. (ISIN: US68213N1090)
What Is the Omnicell Inc Stock Price Today?
The Omnicell Inc stock price today is 42.94.
What Is the Stock Symbol for Omnicell Inc?
The stock ticker symbol for Omnicell Inc is OMCL.
Is OMCL the Same as $OMCL?
$OMCL is a common way to refer to the Omnicell Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Omnicell Inc Trade On?
Omnicell Inc is listed and trades on the NASDAQ stock exchange.
Is Omnicell Inc a Good Stock to Buy?
Determining whether Omnicell Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Omnicell Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OMCL quote. (ISIN: US68213N1090)
42.94
+1.52(+3.66%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.23
43.04
52 wk Range
22.66
55.00
OMCL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.2343.04
52 wk Range
22.6655.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OMCL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
61.29
Upside
+42.72%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Management has been aggressively buying back shares
- Omnicell receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Arm, Rambus among market cap stock movers on Tuesday
- Investing.com
- Omnicell receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 61.29
(+42.72% Upside)
Omnicell Inc SWOT Analysis
Innovation Pipeline | Delve into Omnisphere's potential as a key growth catalyst, leveraging AI and cloud technology to revolutionize pharmacy automation and efficiency |
Financial Outlook | Analysts project modest 3% revenue growth for FY25, with a $40 price target from Wells Fargo Securities, reflecting cautious optimism amid transition |
Market Dynamics | Explore how Omnicell navigates regulatory uncertainties and hospital spending trends while maintaining a strong foothold in medication management solutions |
SaaS Transformation | Omnicell's strategic shift to SaaS and automation in pharmacy operations promises consistent revenue streams and enhanced market positioning |
Omnicell Inc Earnings Call Summary for Q1/2026
- Omnicell Q1 2026 EPS of $0.55 beat forecast by 66.67%; revenue rose 15% YoY to $310M, exceeding expectations; stock surged 20.65% pre-market
- Non-GAAP EBITDA jumped 88% YoY to $45M; gross margin improved to 46% from 42%; GAAP EPS turned positive at $0.25 vs. $0.15 loss in Q1 2025
- Company launched Titan XT automated dispensing system, expected to drive future revenue growth in autonomous medication management market
- Full-year 2026 guidance maintained for bookings and revenue; raised non-GAAP EBITDA outlook to $153M-$168M with linear growth expected throughout year
- Analysts maintain 'Buy' rating with price targets $49-$70; management confident despite supply chain risks and competitive pressures in healthcare tech
Last Updated: 04/28/2026, 09:36 AM
Read Full TranscriptOmnicell investor slides for Q1/2026
Last Update: Apr 28, 2026
See full investor slides
Earnings
Latest Release
Apr 28, 2026
EPS / Forecast
0.55 / 0.33
Revenue / Forecast
309.88M / 304.01M
Compare OMCL to Peers and Sector
Metrics to compare | OMCL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOMCLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 94.8x | 18.3x | −0.5x | |
PEG Ratio | −32.42 | 0.05 | 0.00 | |
Price / Book | 1.5x | 7.4x | 2.6x | |
Price / LTM Sales | 1.6x | 5.7x | 3.2x | |
Upside (Analyst Target) | 44.8% | 37.3% | 48.8% | |
Fair Value Upside | Unlock | −6.6% | 6.9% | Unlock |
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Omnicell (OMCL) Stock Price Today?
The Omnicell stock price today is 42.94 USD.
What Stock Exchange Does Omnicell Trade On?
Omnicell is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Omnicell?
The stock symbol for Omnicell is "OMCL."
What Is the Omnicell Market Cap?
As of today, Omnicell market cap is 1.95B USD.
What Is Omnicell's Earnings Per Share (TTM)?
The Omnicell EPS (TTM) is 0.44.
When Is the Next Omnicell Earnings Date?
Omnicell will release its next earnings report on Jul 30, 2026.
From a Technical Analysis Perspective, Is OMCL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Omnicell Stock Split?
Omnicell has split 0 times.
How Many Employees Does Omnicell Have?
Omnicell has 3580 employees.
What is the current trading status of Omnicell (OMCL)?
As of May 01, 2026, Omnicell (OMCL) is trading at a price of 42.94 USD, with a previous close of 41.42 USD. The stock has fluctuated within a day range of 41.23 USD to 43.04 USD, while its 52-week range spans from 22.66 USD to 55.00 USD.
What Is Omnicell (OMCL) Price Target According to Analysts?
The average 12-month price target for Omnicell is 61.29 USD, with a high estimate of 70 USD and a low estimate of 55 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +42.72% Upside potential.
What Is the OMCL Premarket Price?
OMCL's last pre-market stock price is 41.22 USD. The pre-market share volume is 30.00, and the stock has decreased by -0.20, or -0.48%.
What Is the OMCL After Hours Price?
OMCL's last after hours stock price is 40.61 USD, the stock has decreased by -0.81, or -1.96%.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.